Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: A review

Psychiatry Research

Volumn 262, Issue , 2018, Pages 363-372

  Rachid, Fady ^a  

^a Private practice   (Switzerland)

Author keywords

Depression; Maintenance rTMS; Relapse prevention; Resistance

Indexed keywords

ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DIZZINESS; ELECTROCONVULSIVE THERAPY; EPISTAXIS; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; OTALGIA; PATIENT SAFETY; PRIORITY JOURNAL; RELAPSE; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; SINUS PAIN; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TREMOR; PROCEDURES; SECONDARY PREVENTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

DEPRESSIVE DISORDER, MAJOR; HUMANS; SECONDARY PREVENTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 85029771463     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2017.09.009     Document Type: Review

References (64)

1. Abraham, G., O'Brien, S., Repetitive transcranial magnetic stimulation is useful for maintenance treatment. Can. J. Psychiatry, 47(4), 2002, 386.
2. Bauer, M., Pfennig, A., Severus, E., Whybrow, P.C., Angst, J., Möller, H.J., World Federation of Societies of Biological Psychiatry, Task Force on Unipolar Depressive Disorders, World Federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: update on the acute and continuation treatment of unipolar depressive disorders. World J. Biol. Psychiatry 14:5 (2013), 334–385.
3. Beck, A.T., Beamesderfer, A., Assessment of depression: the depression inventory. Mod. Prob. Pharmacopsychiatr. 7:0 (1974), 151–169.
4. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56:6 (1988), 893–897.
5. Benadhira, R., Saba, G., Samaan, A., Dumortier, G., Lipski, H., Gastal, D., et al. Transcranial magnetic stimulation for refractory depression. Am. J. Psychiatry, 162(1), 2005, 193.
6. Berlim, M.T., Van den Eynde, F., Daskalakis, Z.J., Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacol 38:4 (2013), 543–551.
7. Berlim, M.T., van den Eynde, F., Tovar-Perdomo, S., Daskalakis, Z.J., Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol. Med. 44:2 (2014), 225–239.
8. Brunelin, J., Ben Maklouf, W., Nicolas, A., Saoud, M., Poulet, E., Successful switch to maintenance rTMS after maintenance ECT in refractory bipolar disorder. Brain Stimul. 3:4 (2010), 238–239.
9. Brunelin, J., Jalenques, I., Trojak, B., Attal, J., Szekely, D., Gay, A., et al. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT. Brain Stimul. 7:6 (2014), 855–863 (STEP Group, Poulet, E. STEP Group).
10. Burton, C., Gill, S., Clarke, P., Galletly, C., Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Arch. Womens’ Ment. Health 17:3 (2014), 247–250.
11. Carpenter, L.L., Janicak, P.G., Aaronson, S.T., Boyadjis, T., Brock, D.G., Cook, I.A., et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress. Anxiety 29:7 (2012), 587–596.
12. Chatterjee, B., Kumar, N., Jha, S., Role of repetitive transcranial magnetic stimulation in maintenance treatment of resistant depression. Ind. J. Psychol. Med. 34:3 (2012), 286–289.
13. Chen, J., Zhou, C., Wu, B., Wang, Y., Li, Q., Wei, Y., et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 210:3 (2013), 1260–1264.
14. Conca, A., Hrubos, W., Di Pauli, J., König, P., Hausmann, A., ECT response after relapse during continuation repetitive transcranial magnetic stimulation. A case report. Eur. Psychiatry 19:2 (2004), 118–119.
15. Connolly, K.R., Helmer, A., Cristancho, M.A., Cristancho, P., O'Reardon, J.P., Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J. Clin. Psychiatry 73:4 (2012), 567–573.
16. Dell'Osso, B., Altamura, A.C., Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute and maintenance efficacy. World J. Biol. Psychiatry 10:4 Pt 2 (2009), 673–676.
17. Dell'Osso, B., D'Urso, N., Castellano, F., Ciabatti, M., Altamura, A.C., Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J. ECT 27:2 (2011), 141–144.
18. Dunner, D.L., Aaronson, S.T., Sackeim, H.A., Janicak, P.G., Carpenter, L.L., Boyadjis, T., et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmaco-resistant major depressive disorder: durability of benefit over a 1-year follow-up period. J. Clin. Psychiatry 75:12 (2014), 1394–1401.
19. Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J., The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33:6 (1976), 766–771.
20. Fitzgerald, P.B., Grace, N., Hoy, K.E., Bailey, M., Daskalakis, Z.J., An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul. 6:3 (2013), 292–297.
21. Folkerts, H.W., Michael, N., Tölle, R., Schonauer, K., Mücke, S., Schulze-Mönking, H., ECT vs. paroxetine in the treatment resistant depression. Acta Psychiatr. Scand. 96:5 (1997), 334–342.
22. Freitas, C., Pearlman, C., Pascual-Leone, A., Treatment of auditory verbal hallucinations with transcranial magnetic stimulation in a patient with psychotic major depression: one-year follow-up. Neurocase 18:1 (2012), 57–65.
23. Gaynes, B.N., Warden, D., Trivedi, M.H., What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr. Serv. 60:11 (2009), 1439–1445.
24. Gaynes, B.N., Lloyd, S.W., Lux, L., Gartlehner, G., Hansen, R.A., Brode, S., et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J. Clin. Psychiatry, 75(5), 2014 (477-448).
25. Guy, W., The Clinical Global Impression Scale. In: ECDEU Assessment Manual For Psychopharmacology – Revised. 1976, US Dept. of Health, Education and Welfare, ADAMHA, MIMH Psychopharmacology Research Branch, Rockville, MD, 218–222.
26. Haddock, G., McCarron, J., Tarrier, N., Faragher, E.B., Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol. Med. 29:4 (1999), 879–889.
27. Haesebaert, F., Moirand, R., Schott-Pethelaz, A.M., Brunelin, J., Poulet, E., Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression. World J. Biol. Psychiatry, 2016, 1–16.
28. Hallett, M., Transcranial magnetic stimulation: a primer. Neuron 55:2 (2007), 187–199.
29. Hamilton, M., Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:4 (1967), 278–296.
30. Hirschfeld, R.M., Clinical importance of long-term antidepressant treatment. Br. J. Psychiatry 42 (2001), S4–S8.
31. Hoffman, R.E., Hawkins, K.A., Gueorguieva, R., Boutros, N.N., Rachid, F., Carroll, K., et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch. Gen. Psychiatry 60:1 (2003), 49–56.
32. Kroenke, K., Spitzer, R.L., Williams, J.B.W., The PHQ-9: validity of a brief depression severity measure. J. Gen. Int. Med. 16:9 (2001), 606–613.
33. Lam, R.W., Chan, P., Wilkins-Ho, M., Yatham, L.N., Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Can. J. Psychiatry 53:9 (2008), 621–631.
34. Langguth, B., Landgrebe, M., Zowe, M., Gerst, M., Hajak, G., Eichhammer, P., Repetitive transcranial magnetic stimulation for maintenance treatment of depression: a case report. J. Clin. Psychiatry 67:5 (2006), 835–836.
35. Li, X., Nahas, Z., Anderson, B., Kozel, F.A., George, M.S., Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?. Depress. Anxiety 20:2 (2004), 98–100.
36. McLoughlin, D.M., Mogg, A., Eranti, S., Pluck, G., Purvis, R., Edwards, D., et al. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. Health Technol. Assess. 11:24 (2007), 1–54.
37. McMahon, E.M., Buszewicz, M., Griffin, M., Beecham, J., Bonin, E.M., Rost, F., et al. Chronic and recurrent depression in primary care: socio-demographic features, morbidity, and costs. Int. J. Fam. Med., 2012, 2012, 316409.
38. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979), 382–389.
39. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., Ustun, B., Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:9590 (2007), 851–858.
40. Mulder, R.T., Frampton, C.M., Outcome of mood disorders before psychopharmacology: a systematic review. Aust. N. Z. J. Psychiatry 48:3 (2014), 224–236.
41. Nemeroff, C.B., Prevalence and management of treatment-resistant depression. J. Clin. Psychiatry 68:Suppl. 8 (2007), 17–25.
42. O'Reardon, J.P., Blumner, K.H., Peshek, A.D., Pradilla, R.R., Pimiento, P.C., Long-term maintenance therapy for major depressive disorder with rTMS. J. Clin. Psychiatry 66:12 (2005), 1524–1528.
43. Overall, J.E., Gorham, D.R., The brief psychiatric rating scale. Psychol. Rep. 10 (1962), 799–812.
44. Özten, E., Sayar, G.H., Karamustafalıoğlu, K.O., Acute and maintenance transcranial magnetic stimulation in a pregnant woman with major depression: a case report. OA Case Rep., 2(3), 2013, 22.
45. Paykel, E.S., Continuation and maintenance therapy in depression. Br. Med. Bull. 57 (2001), 145–159.
46. Philip, N.S., Dunner, D.L., Dowd, S.M., Aaronson, S.T., Brock, D.G., Carpenter, L.L., et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 9:2 (2016), 251–257.
47. Prudic, J., Olfson, M., Marcus, S.C., Fuller, R.B., Sackeim, H.A., Effectiveness of electroconvulsive therapy in community settings. Biol. Psychiatry 55:3 (2004), 301–312.
48. Richieri, R., Guedj, E., Michel, P., Loundou, A., Auquier, P., Lançon, C., et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J. Affect. Disord. 151:1 (2013), 129–135.
49. Rossi, S., Hallett, M., Rossini, P.M., Pascual-Leone, A., Safety of TMS Consensus Group, Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120:12 (2009), 2008–2039.
50. Rush, A.J., Thase, M.E., Dubé S., Research issues in the study of difficult-to-treat depression. Biol. Psychiatry 53:8 (2003), 743–753.
51. Rush, A.J., Warden, D., Wisniewski, S.R., Fava, M., Trivedi, M.H., Gaynes, B.N., et al. STAR*D: revising conventional wisdom. CNS Drugs 23:8 (2009), 627–647.
52. Sackeim, H.A., The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry 62:Suppl. 16 (2001), 10–17.
53. Schutter, D.J., Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol. Med. 39:1 (2009), 65–75.
54. Slotema, C.W., Blom, J.D., Hoek, H.W., Sommer, I.E., Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J. Clin. Psychiatry 71:7 (2010), 873–884.
55. Spielberger, C.D., Gorsuch, R.L., Lushene, P.R., Vagg, P.R., Jacobs, G.A., Manual for the State-Trait Anxiety Inventory (Form Y). 1983, Consulting Psychologists Press, Inc., Palo Alto.
56. Szuba, M.P., O'Reardon, J.P., Rai, A.S., Snyder-Kastenberg, J., Amsterdam, J.D., Gettes, D.R., et al. Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biol. Psychiatry 50:1 (2005), 22–27.
57. Thase, M.E., Rush, A.J., When at first you don't succeed: sequential strategies for antidepressant non-responders. J. Clin. Psychiatry 58:Suppl. 13 (1997), 23–29.
58. Wagner, T., Valero-Cabre, A., Pascual-Leone, A., Non-invasive human brain stimulation. Annu. Rev. Biomed. Eng. 9 (2007), 527–565.
59. Wassermann, E.M., Lisanby, S.H., Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin. Neurophysiol. 112:8 (2001), 1367–1377.
60. World Health Organization [Internet]. Global health risks: mortality and burden of disease attributable to selected major risks; p8. Available from: 〈 http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf〉. Cited 2013 May 8. World Health Organization. Fact Sheet No. 369. 〈 http://www.who.int/mediacentre/factsheets/fs369/en/〉 2012. 2009.
61. Young, R.C., Biggs, J.T., Ziegler, V.E., Meyer, D.A., A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978), 429–435.
62. Zhang, Y.Q., Zhu, D., Zhou, X.Y., Liu, Y.Y., Qin, B., Ren, G.P., et al. Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Braz. J. Med. Biol. Res. 48:3 (2015), 198–206.
63. Zivin, K., Ilgen, M.A., Pfeiffer, P.N., Welsh, D.E., McCarthy, J., Valenstein, M., et al. Early mortality and years of potential life lost among veterans affairs patients with depression. Psychiatr. Serv. 63 (2012), 823–826.
64. Zung, W., A self-rating depression scale. Arch. Gen. Psychiatry 12 (1965), 63–70.